Weight-loss drug Wegovy to hit market
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on euronews
Wegovy weight loss: The science and the hype
Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads. Here's what you need to know.
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO).
Weight-loss drug Wegovy to hit market on Tuesday
Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order through Zeullig Pharma Korea.
Weight loss drugs have one big issue; These companies want to fix it
Read which pharmaceutical companies are addressing the risk of muscle mass loss associated with popular weight loss drugs from Novo (NOVO) and Eli Lilly (LLY).
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold unbranded copies of those drugs are mounting a coordinated effort to reverse this decision,
Wegovy and Zepbound rival targeting ‘next generation' of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...
WeightWatchers Is Offering Knockoff Wegovy. The Market Is Already Crowded.
The compounding pharmacies that supply knockoff Wegovy can only legally make it as long as it remains on the Food and Drug ...
Thousands of people with life-threatening obesity denied access to weight-loss jab Wegovy
Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...
Best OTC Wegovy Alternatives: Natural Options for Effective Weight Management
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.
Yahoo Finance4d
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
Dozens of companies, large and small, have set out to test experimental medicines they claim could be more potent, convenient or have fewer side effects than Novo’s Wegovy and Lilly’s Zepbound.
tyla3d
Difference between Ozempic, Wegovy, Mounjaro and Saxenda explained
Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...
Catalent to Sell New Jersey Facility
(Reuters) - Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New ...